Zacks: Cellect Biotech/S (Apop) Given Consensus Rating of "Strong Buy" by Analysts
CELLECT BIOTECH/S has been given an average broker rating score of 1.00 from the one brokers that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.
from Biotech News
0 Comments